Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Aspirin in Treating Patients With Colorectal Cancer That Has Been Surgically Removed

ClinicalTrials.gov ID: NCT00002527

Public ClinicalTrials.gov record NCT00002527. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 2, 2026, 10:10 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Colorectal Adenoma Chemoprevention Trial Using Aspirin: A Phase III Study

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

RATIONALE: Chemoprevention therapy is the use of certain drugs to try to prevent the development or recurrence of cancer. The use of aspirin may be an effective way to prevent the recurrence of polyps in colorectal cancer. PURPOSE: Randomized phase III trial to study the effectiveness of aspirin in treating patients who have stage I, stage II, or stage III colorectal cancer that has been surgically removed.

Study identification

NCT ID
NCT00002527
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Enrollment
635 participants

Conditions and interventions

Interventions

Drug · Other

Eligibility (public fields only)

Age range
30 Years to 74 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 1993 (Type not available)
Primary completion
Mar 2003 (Actual)
Completion
Jan 2006 (Actual)
Last update posted
Jul 4, 2016

1993 – 2006

United States locations

U.S. sites
41
U.S. states
24
U.S. cities
40
Facility City State ZIP Site status
CCOP - Scottsdale Oncology Program Scottsdale Arizona 85259-5404 —
UCSF Cancer Center and Cancer Research Institute San Francisco California 94115-0128 —
CCOP - Mount Sinai Medical Center Miami Beach Florida 33140 —
University of Chicago Cancer Research Center Chicago Illinois 60637 —
CCOP - Illinois Oncology Research Association Peoria Illinois 61602 —
CCOP - Carle Cancer Center Urbana Illinois 61801 —
CCOP - Cedar Rapids Oncology Project Cedar Rapids Iowa 52403-1206 —
CCOP - Iowa Oncology Research Association Des Moines Iowa 10309-1016 —
University of Iowa Hospitals and Clinics Iowa City Iowa 52242 —
Siouxland Hematology-Oncology Sioux City Iowa 51101-1733 —
CCOP - Ochsner New Orleans Louisiana 70121 —
Marlene & Stewart Greenebaum Cancer Center, University of Maryland Baltimore Maryland 21201 —
Massachusetts General Hospital Cancer Center Boston Massachusetts 02114 —
University of Massachusetts Memorial Medical Center Worcester Massachusetts 01655 —
CCOP - Ann Arbor Regional Ann Arbor Michigan 48106 —
University of Minnesota Cancer Center Minneapolis Minnesota 55455 —
Mayo Clinic Cancer Center Rochester Minnesota 55905 —
CentraCare Clinic Saint Cloud Minnesota 56303 —
Ellis Fischel Cancer Center - Columbia Columbia Missouri 65203 —
Barnes-Jewish Hospital St Louis Missouri 63110 —
CCOP - Missouri Valley Cancer Consortium Omaha Nebraska 68131 —
CCOP - Southern Nevada Cancer Research Foundation Las Vegas Nevada 89106 —
Norris Cotton Cancer Center Lebanon New Hampshire 03756 —
Roswell Park Cancer Institute Buffalo New York 14263-0001 —
CCOP - North Shore University Hospital Manhasset New York 11030 —
New York Presbyterian Hospital - Cornell Campus New York New York 10021 —
State University of New York - Upstate Medical University Syracuse New York 13210 —
Lineberger Comprehensive Cancer Center, UNC Chapel Hill North Carolina 27599-7295 —
CCOP - Southeast Cancer Control Consortium Winston-Salem North Carolina 27104-4241 —
Comprehensive Cancer Center of Wake Forest University Baptist Medical Center Winston-Salem North Carolina 27157-1082 —
Quain & Ramstad Clinic, P.C. Bismarck North Dakota 58501 —
CCOP - Merit Care Hospital Fargo North Dakota 58122 —
Altru Health Systems Grand Forks North Dakota 58201 —
CCOP - Toledo Community Hospital Oncology Program Toledo Ohio 43623-3456 —
CCOP - Geisinger Clinical and Medical Center Danville Pennsylvania 17822-2001 —
Rhode Island Hospital Providence Rhode Island 02903 —
Rapid City Regional Hospital Rapid City South Dakota 57709 —
CCOP - Sioux Community Cancer Consortium Sioux Falls South Dakota 57105-1080 —
University of Tennessee, Memphis Cancer Center Memphis Tennessee 38163 —
Vermont Cancer Center Burlington Vermont 05401-3498 —
MBCCOP - Massey Cancer Center Richmond Virginia 23298-0037 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00002527, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 4, 2016 · Synced Oct 2, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00002527 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →